Acetaldehyde → HCID 73505015, 화합물

HRID 590825노트

반응식

HRID 590825 반응식
[NH2:1][C:2]1[C:6]2[C:7]([CH2:23][O:24][CH3:25])=[N:8][C:9]([NH:11][C:12]([NH:14][C@@H:15]([C:17]3[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=3)[CH3:16])=[O:13])=[CH:10][C:5]=2[NH:4][N:3]=1.[O-]S([O-])(=O)=O.[Mg+2].[C:32](O)([C:34](F)(F)F)=O.C(=O)C.C([BH3-])#N.[Na+]>C(Cl)(Cl)Cl.CO>[CH2:32]([NH:1][C:2]1[C:6]2[C:7]([CH2:23][O:24][CH3:25])=[N:8][C:9]([NH:11][C:12]([NH:14][C@@H:15]([C:17]3[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=3)[CH3:16])=[O:13])=[CH:10][C:5]=2[NH:4][N:3]=1)[CH3:34]

참가 물질

8

실험 절차

A solution of (R)-1-(3-amino-4-(methoxymethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl)-3-(1-phenylethyl)urea (34.8 mg, 0.102 mmol) in chloroform (0.6 ml) and MeOH (0.3 ml) was charged with MgSO4 (45 mg, 0.374 mmol), TFA (24 μl, 0.312 mmol) and acetaldehyde (0.02 ml, 0.354 mmol). The mixture was stirred at RT for 1 hr, then charged with sodium cyanoborohydride (22 mg, 0.350 mmol) before it was stirred at RT for 1.5 hr. The mixture was filtered to remove insoluble matter, rinsing with MeOH and DCM and concentrated in vacuo. The residue was purified by mass-triggered reverse-phase HPLC to provide (R)-1-(3-(ethylamino)-4-(methoxymethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl)-3-(1-phenylethyl)urea. MS ESI calc'd for C19H25N6O2 [M+H]+ 369. found 369. 1H NMR (ppm, 500 MHz, DMSO-d6) δ 11.64 (s, 1H), 8.96 (s, 1H), 7.33 (m, 4H), 7.23 (m, 1H), 7.15 (s, 1H), 5.56 (t, J=6.5 Hz, 1H), 4.85 (t, J=7.3 Hz), 4.63 (m, 2H), 3.32 (s, 3H, overlaps with H2O peak), 3.22 (m, 2H), 1.39 (d, 6.8 Hz, 3H), 1.20 (t, J=4.9 Hz, 3H).

후처리

  1. stirringwas stirred at RT for 1.5 hr
  2. filtrationThe mixture was filtered
  3. customto remove insoluble matter
  4. washrinsing with MeOH and DCM
  5. concentrationconcentrated in vacuo
  6. customThe residue was purified by mass-triggered reverse-phase HPLC

출처 및 근거

ORD 기록
ord-91b0ad1d6cb340de9e03937238ad4a15
출처 데이터셋
uspto-grants-2016_01
특허 번호
US09233979B2

반응 노트

불러오는 중…